Format

Send to

Choose Destination
BMC Complement Altern Med. 2013 Oct 26;13:284. doi: 10.1186/1472-6882-13-284.

An in vitro study on the risk of non-allergic type-I like hypersensitivity to Momordica charantia.

Author information

1
Transplantation Laboratory, Division of Immunology and Allergy Diseases, Gulhane Military Medical Academy, Ankara, Turkey. rilikci@gata.edu.tr.

Abstract

BACKGROUND:

Momordica charantia (MC) is a tropical plant that is extensively used in folk medicine. However, the knowledge about side effects of this plant is relatively little according to knowledge about its therapeutic effects. The aim of this study is to reveal the effects of non-allergic type-I like hypersensitivity to MC by an experiment which was designed in vitro.

METHODS:

In the present study, the expression of CD63 and CD203c on peripheral blood basophils against different dilutions of MC extracts was measured using flow cytometry and compared with one another. In addition to this, intra-assay CV's of testing extracts were calculated for precision on reproducibility of test results.

RESULTS:

It was observed that the fruit extract of MC at 1/100 and 1/1000 dilutions significantly increased active basophils compared to same extract at 1/10000 dilution.

CONCLUSIONS:

In conclusion, Momordica charantia may elicit a non-allergic type-I like hypersensitivity reaction in especially susceptible individuals.

PMID:
24160670
PMCID:
PMC3827325
DOI:
10.1186/1472-6882-13-284
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center